MX9709011A - Composicion de vacuna que comprende fosfato de poliribosilribitol y su procedimiento de fabricacion. - Google Patents
Composicion de vacuna que comprende fosfato de poliribosilribitol y su procedimiento de fabricacion.Info
- Publication number
- MX9709011A MX9709011A MX9709011A MX9709011A MX9709011A MX 9709011 A MX9709011 A MX 9709011A MX 9709011 A MX9709011 A MX 9709011A MX 9709011 A MX9709011 A MX 9709011A MX 9709011 A MX9709011 A MX 9709011A
- Authority
- MX
- Mexico
- Prior art keywords
- vaccine composition
- composition containing
- making same
- polyribosylribitol phosphate
- aluminium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
La invencion se refiere a una composicion de vacuna que comprende cuando menos un antígeno constituido por el polisacárido de tipo b Haemophilus influenza tipo b o fosfato poliribosilribitol de alto peso molecular acoplado a la anatoxina tetánica así como un auxiliar o agregado a base de aluminio, en el cual el agregado a base de aluminio presenta por naturaleza o después de la adicion de aniones un punto de carga cero inferior a cerca de 7.2. La invencion tiene igualmente por objeto un procedimiento de preparacion de tal composicion de vacuna.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR95/06417 | 1995-05-24 | ||
| FR9506417A FR2734484B1 (fr) | 1995-05-24 | 1995-05-24 | Composition vaccinale liquide et procede de fabrication |
| PCT/FR1996/000791 WO1996037222A1 (fr) | 1995-05-24 | 1996-05-24 | Composition vaccinale comprenant du polyribosylribitol phosphate et son procede de fabrication |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9709011A true MX9709011A (es) | 1998-03-31 |
| MXPA97009011A MXPA97009011A (es) | 1998-10-15 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199700419A1 (ru) | Вакцинная композиция, содержащая полирибозилрибитолфосфат, и способ ее получения | |
| AU561978B2 (en) | Haemophilus influenzae b polysaccharide-diptheria toxoid conjugate vaccine | |
| AU8483391A (en) | Improved oligosaccharide conjugate vaccines | |
| EP0914153B8 (en) | Multivalent dtp-polio vaccines | |
| DE3682838D1 (de) | Glycoproteinkonjugate mit trivalenter immunogener aktivitaet. | |
| HK1041825A1 (en) | A polysaccharide-protein conjugate or oligosaccharide-protein conjugate, a method for producing the same, and its uses thereof | |
| CA2071811A1 (en) | Improved meningococcal polysaccharide conjugate vaccine | |
| ES8401722A1 (es) | Procedimiento de obtencion de vacunas contra el patogeno h influenzae tipo b. | |
| AU3760795A (en) | Synthesis of typhoid fever vaccine from a plant or fruit polysaccharide | |
| UA27754C2 (uk) | Комбінована педіатрична вакцина, спосіб одночасної комбінованої вакцинації | |
| ES8502339A1 (es) | Procedimiento de obtencion de una vacuna para ejercer la formacion de anticuerpo de fosfato de poliribosilribitol (prp) en un animal de sangre caliente | |
| WO1990015132A3 (en) | Cloned treponema hyodysenteriae endoflagellar antigen | |
| MX9710521A (es) | Una composicion de vacuna comprendiendo un antigeno conjugado de polisacarido adsorbido en fosfato de aluminio. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| HC | Change of company name or juridical status |
Owner name: ADWEN OFFSHORE S.L. |